Neurotransmitters, neuropeptides and calcium binding proteins in developing human cerebellum: a review.
Many endogenous neurochemicals that are known to have important functions in the mature central nervous system have also been found in the developing human cerebellum. Cholinergic neurons, as revealed by immunoreactivities towards choline acetyltransferase or acetylcholinesterase, appear early at 23 weeks of gestation in the cerebellar cortex and deep nuclei. Immunoreactivities gradually increase until the first postnatal month. Enkephalin is localized in the developing cerebellum, initially in the fibers of the cortex and deep nuclei at 16-20 weeks and then also in the Purkinje cells, granule cells, basket cells and Golgi cells at 23 weeks onward. Another neuropeptide, substance P, is localized mainly in the fibers of the dentate nucleus from 9 to 24 weeks but substance P immunoreactivity declines thereafter. GABA, an inhibitory neurotransmitter of the central nervous system, starts to appear at 16 weeks in the Purkinje cells, stellate cells, basket cells, mossy fibers and neurons of deep nuclei. GABA expression is gradually upregulated toward term forming networks of GABA-positive fibers and neurons. Catecholaminergic fibers and neurons are also detected in the cortex and deep nuclei at as early as 16 weeks. Calcium binding proteins, calbindin D28K and parvalbumin, make their first appearance in the cortex and deep nuclei at 14 weeks and then their expression decreases toward term, while calretinin appears later at 21 weeks but its expression increases with fetal age. The above findings suggest that many neurotransmitters, neuropeptides and calcium binding proteins (1) appear early during development of the cerebellum; (2) have specific temporal and spatial expression patterns; (3) may have functions other than those found in the mature neural systems; and (4) may be able to interact with each other during early development.
Kwong
W H
WH
Department of Anatomy, Faculty of Medicine, The Chinese University of Hong Kong.
Chan
W Y
WY
Lee
K K
KK
Fan
M
M
Yew
D T
DT
D000818:Animals; D002135:Calcium-Binding Proteins / Q000378:metabolism* / Q000502:physiology; D002531:Cerebellum / Q000196:embryology* / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004745:Enkephalins / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D009412:Nerve Fibers / Q000378:metabolism / Q000502:physiology; D009474:Neurons / Q000378:metabolism / Q000502:physiology; D009479:Neuropeptides / Q000378:metabolism* / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism* / Q000502:physiology; D018079:Receptors, GABA / Q000378:metabolism; D017470:Receptors, Glutamate / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D002135:Calcium-Binding Proteins; D004745:Enkephalins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D018079:Receptors, GABA; D017470:Receptors, Glutamate; D011985:Receptors, Serotonin; D012701:Serotonin; D013373:Substance P; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D002795:Choline O-Acetyltransferase